Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| Pamukkale University | Registry Identifier | Pamukkale University |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Study Purpose The purpose of this observational study is to determine the prevalence of temporomandibular dysfunction (TMD) in individuals diagnosed with Sjögren's syndrome and to examine the relationship between disease activity and TMD.
The main question to be answered is: Is TMD more common in individuals with Sjögren's syndrome, and is there a relationship between disease activity and TMD?
Method Participants diagnosed with Sjögren's syndrome will be evaluated. The prevalence and severity of TMD will be examined along with mouth opening, head posture, and oral health parameters.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group I | patients with primary Sjögren syndrome (pSS) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Temporomandibular Joint Function | Diagnostic Test | Temporomandibular joint function and predictive parameters in patients with primary Sjögren Syndrome (pSS) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Fonseca Anamnestic Index (FAI) | Assesses the severity of TMD. As the score increases, the TMD severity (none, mild, moderate, severe) worsens. (0-15: None, 20-45: Mild, 50-65: Moderate, 70-100: Severe) | Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period. |
| EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI) | Evaluates disease activity. A high score (5 and above) indicates high disease activity. (The higher the average score, the more severe the symptoms of fatigue, pain, and dryness.) | Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period. |
| Measure | Description | Time Frame |
|---|---|---|
| Xerostomia Inventory | Measures the severity of dry mouth (xerostomia) symptoms. A higher score indicates more severe xerostomia symptoms. | Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period. |
| Oral Health-Related Quality of Life - UK Scale |
Not provided
-Inclusion Criteria Individuals between 18 and 65 years of age. Must have a confirmed diagnosis of Sjögren's Syndrome. Must possess the mental capacity and education to understand the significance of the research.
Must be volunteers willing to participate in the study.
-Exclusion Criteria Incomplete questionnaires/scales. History of orthodontic treatment within the last six months. Presence of neurological or cognitive deficit. Patients with a history of pathology related to the temporomandibular joint (TMJ) and associated structures prior to the diagnosis of Sjögren's Syndrome.
Woman
Women with Sjögren's Syndrome
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pamukkale University | Pamukkale | Denizli | 20000 | Turkey (Türkiye) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D012859 | Sjogren's Syndrome |
| ID | Term |
|---|---|
| D001172 | Arthritis, Rheumatoid |
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Assesses oral health-related quality of life. An increase in score generally indicates a greater deterioration in quality of life (i.e., worse oral health impact). |
| Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period. |
| Visual Analog Scale (VAS) for Disease Involvement | Numerically evaluates the severity of specific symptoms like dry mouth, dry eyes, facial skin dryness, and lip dryness. As the score approaches 10, the severity of dryness reaches its highest level. | Evaluations started immediately after receiving ethics committee approval and will be completed within 6 months, which is the study period. |
| D012216 |
| Rheumatic Diseases |
| D014987 | Xerostomia |
| D012466 | Salivary Gland Diseases |
| D009059 | Mouth Diseases |
| D009057 | Stomatognathic Diseases |
| D015352 | Dry Eye Syndromes |
| D007766 | Lacrimal Apparatus Diseases |
| D005128 | Eye Diseases |
| D003240 | Connective Tissue Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |